Iolyx Therapeutics

Manufacturer of a clinical-stage company intending to transform the standard of care for ocular disease at the intersection of immunology and ophthalmology. The company's platform offers tailored form...

Business Products and Services (B2B)
Burlingame, CA, United States
Founded 2019
4 employees
Website
Valuation
$64M
Market implied
Share Price
N/A
Total Raised
$45M
Last Round
N/A

Get the full picture

Create a free account to unlock Iolyx Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required